BUPROPION HYDROCHLORIDE — all Canadian products
36 DINs
16 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BUPROPION HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02385694 | BUPROPION HCL SR | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Approved | |
| 02383187 | BUPROPION HCL XL | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Approved | |
| 02383195 | BUPROPION HCL XL | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Approved | |
| 02561158 | BUPROPION HYDROCHLORIDE XL | YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Approved | |
| 02561131 | BUPROPION HYDROCHLORIDE XL | YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Approved | |
| 02275074 | ODAN BUPROPION SR | ODAN LABORATORIESLTD | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Marketed | |
| 02275082 | ODAN BUPROPION SR | ODAN LABORATORIESLTD | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02565838 | ODAN-BUPROPION XL | ODAN LABORATORIESLTD | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02565846 | ODAN-BUPROPION XL | ODAN LABORATORIESLTD | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Marketed | |
| 02475812 | TARO-BUPROPION XL | SUN PHARMA CANADA INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Marketed | |
| 02475804 | TARO-BUPROPION XL | SUN PHARMA CANADA INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02439662 | TEVA-BUPROPION XL | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Marketed | |
| 02439654 | TEVA-BUPROPION XL | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02275104 | WELLBUTRIN XL | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Marketed | |
| 02275090 | WELLBUTRIN XL | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02238441 | ZYBAN | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Marketed | |
| 02363399 | AVA-BUPROPION SR | AVANSTRA INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02363402 | AVA-BUPROPION SR | AVANSTRA INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02325357 | BUPROPION SR | PRO DOC LIMITEE | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02391562 | BUPROPION SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02331616 | BUPROPION SR | PRO DOC LIMITEE | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02391570 | BUPROPION SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02331829 | DOM-BUPROPION SR | DOMINION PHARMACAL | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Pre Market | |
| 02317761 | DOM-BUPROPION SR | DOMINION PHARMACAL | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Pre Market | |
| 02382083 | MYLAN-BUPROPION XL | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 300 MG | Cancelled Post Market | |
| 02382075 | MYLAN-BUPROPION XL | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02299461 | NOVO-BUPROPION SR | NOVOPHARM LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Pre Market | |
| 02260239 | NOVO-BUPROPION SR TABLETS | NOVOPHARM LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02331810 | PHL-BUPROPION SR | PHARMEL INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Pre Market | |
| 02317788 | PHL-BUPROPION SR | PHARMEL INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Pre Market | |
| 02313421 | PMS-BUPROPION SR | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02325373 | PMS-BUPROPION SR | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02285665 | RATIO-BUPROPION SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02285657 | RATIO-BUPROPION SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02237824 | WELLBUTRIN SR | BIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02237825 | WELLBUTRIN SR | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | BUPROPION HYDROCHLORIDE 150 MG | Dormant |
Browse other molecules: